Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.

Bockerstett KA, Lewis SA, Wolf KJ, Noto CN, Jackson NM, Ford EL, Ahn TH, DiPaolo RJ.

Gut. 2019 Sep 3. pii: gutjnl-2019-318930. doi: 10.1136/gutjnl-2019-318930. [Epub ahead of print]

2.

The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia.

Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M.

Mol Neurobiol. 2019 Aug 31. doi: 10.1007/s12035-019-01737-z. [Epub ahead of print] Review.

PMID:
31473906
3.

How challenging is to manage agitated patients?

Cavalcante DA, Gadelha A, Noto C.

Braz J Psychiatry. 2019 Jul-Aug;41(4):277-278. doi: 10.1590/1516-4446-2019-4105. No abstract available.

4.

Corrigendum to "Oxidative and nitrosative stress biomarkers in chronic schizophrenia".

Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Teixeira AL, Brietzke E, Pedrini M, Asevedo E, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG.

Psychiatry Res. 2019 Mar;273:809. doi: 10.1016/j.psychres.2019.03.020. No abstract available.

PMID:
31185578
5.

An Enigmatic Small Neosuchian Crocodyliform from the Woodbine Formation of Texas.

Noto CR, Drumheller SK, Adams TL, Turner AH.

Anat Rec (Hoboken). 2019 Jun 7. doi: 10.1002/ar.24174. [Epub ahead of print]

PMID:
31173481
6.

Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis.

Malinowski FR, Tasso BC, Ortiz BB, Higuchi CH, Noto C, Belangero SI, Bressan RA, Gadelha A, Cordeiro Q.

Braz J Psychiatry. 2019 May 30. pii: S1516-44462019005009101. doi: 10.1590/1516-4446-2018-0237. [Epub ahead of print]

7.

Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial.

Rabanea-Souza T, Cirigola SMC, Noto C, Gomes JS, Azevedo CC, Gadelha A, Cordeiro Q, Dias ÁM, Lacerda ALT.

Trials. 2019 Apr 5;20(1):199. doi: 10.1186/s13063-019-3288-5.

8.

Gene expression over the course of schizophrenia: from clinical high-risk for psychosis to chronic stages.

Ota VK, Moretti PN, Santoro ML, Talarico F, Spindola LM, Xavier G, Carvalho CM, Marques DF, Costa GO, Pellegrino R, de Jong S, Cordeiro Q, Hakonarson H, Breen G, Noto C, Bressan RA, Gadelha A, Jesus Mari J, Belangero SI.

NPJ Schizophr. 2019 Mar 28;5(1):5. doi: 10.1038/s41537-019-0073-0.

9.

DGCR2 influences cortical thickness through a mechanism independent of schizophrenia pathogenesis.

Belangero SI, Ota VK, Gadelha A, Berberian AA, Assunção-Leme IB, Noto C, Christofolini DM, Bellucco FT, Santoro ML, Mazzotti DR, Zugman A, Melaragno MI, Smith MAC, Pellegrino R, Hakonarson H, Cordeiro Q, Moretti PN, Bressan RA, Mari JJ, Jackowski AP.

Psychiatry Res. 2019 Apr;274:391-394. doi: 10.1016/j.psychres.2019.02.068. Epub 2019 Feb 27.

PMID:
30901624
10.

Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.

Dal Mas C, Nani JV, Noto C, Yonamine CM, da Cunha GR, Mansur RB, Ota VK, Belangero SI, Cordeiro Q, Kapczinski F, Brietzke E, Bressan RA, Gadelha A, Hayashi MAF.

Schizophr Res. 2019 Jun;208:202-208. doi: 10.1016/j.schres.2019.02.021. Epub 2019 Mar 8.

PMID:
30857875
11.

Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis.

Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI, Gadelha A, Bressan RA, Noto C.

Eur Neuropsychopharmacol. 2019 Mar;29(3):416-431. doi: 10.1016/j.euroneuro.2018.12.008. Epub 2018 Dec 26.

PMID:
30594344
12.

Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals.

Coutinho LS, Honorato H, Higuchi CH, Cavalcante DA, Belangeiro S, Noto M, Bressan RA, Cordeiro Q, Noto C, Gadelha A.

Schizophr Res Cogn. 2018 Dec 11;16:12-16. doi: 10.1016/j.scog.2018.10.002. eCollection 2019 Jun.

13.

Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder.

de Jong S, Diniz MJA, Saloma A, Gadelha A, Santoro ML, Ota VK, Noto C; Major Depressive Disorder and Bipolar Disorder Working Groups of the Psychiatric Genomics Consortium, Curtis C, Newhouse SJ, Patel H, Hall LS, O Reilly PF, Belangero SI, Bressan RA, Breen G.

Commun Biol. 2018 Oct 8;1:163. doi: 10.1038/s42003-018-0155-y. eCollection 2018.

14.

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort.

Santoro ML, Ota V, de Jong S, Noto C, Spindola LM, Talarico F, Gouvea E, Lee SH, Moretti P, Curtis C, Patel H, Newhouse S, Carvalho CM, Gadelha A, Cordeiro Q, Bressan RA, Belangero SI, Breen G.

Transl Psychiatry. 2018 Aug 31;8(1):174. doi: 10.1038/s41398-018-0230-7.

15.

An unusual association of hadrosaur and therizinosaur tracks within Late Cretaceous rocks of Denali National Park, Alaska.

Fiorillo AR, McCarthy PJ, Kobayashi Y, Tomsich CS, Tykoski RS, Lee YN, Tanaka T, Noto CR.

Sci Rep. 2018 Aug 3;8(1):11706. doi: 10.1038/s41598-018-30110-8.

16.

Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach.

de Moura AM, Pinaya WHL, Gadelha A, Zugman A, Noto C, Cordeiro Q, Belangero SI, Jackowski AP, Bressan RA, Sato JR.

Psychiatry Res Neuroimaging. 2018 May 30;275:14-20. doi: 10.1016/j.pscychresns.2018.03.003. Epub 2018 Mar 6.

PMID:
29548527
17.

Accessing Gene Expression in Treatment-Resistant Schizophrenia.

Moretti PN, Ota VK, Gouvea ES, Pedrini M, Santoro ML, Talarico F, Spindola LM, Carvalho CM, Noto C, Xavier G, Brietzke E, Gadelha A, Bressan R, Mari J, Belangero S.

Mol Neurobiol. 2018 Aug;55(8):7000-7008. doi: 10.1007/s12035-018-0876-4. Epub 2018 Jan 26.

PMID:
29374346
18.

Leukocyte telomere length variation in different stages of schizophrenia.

Maurya PK, Rizzo LB, Xavier G, Tempaku PF, Ota VK, Santoro ML, Spíndola LM, Moretti PS, Mazzotti DR, Gadelha A, Gouvea ES, Noto C, Maes M, Cordeiro Q, Bressan RA, Brietzke E, Belangero SI.

J Psychiatr Res. 2018 Jan;96:218-223. doi: 10.1016/j.jpsychires.2017.10.016. Epub 2017 Oct 21.

PMID:
29102816
19.

New data towards the development of a comprehensive taphonomic framework for the Late Jurassic Cleveland-Lloyd Dinosaur Quarry, Central Utah.

Peterson JE, Warnock JP, Eberhart SL, Clawson SR, Noto CR.

PeerJ. 2017 Jun 6;5:e3368. doi: 10.7717/peerj.3368. eCollection 2017.

20.

Oxidative and nitrosative stress biomarkers in chronic schizophrenia.

Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG.

Psychiatry Res. 2017 Jul;253:43-48. doi: 10.1016/j.psychres.2017.03.038. Epub 2017 Mar 21. Erratum in: Psychiatry Res. 2019 Mar;273:809.

PMID:
28346888
21.

Shorter leukocyte telomere length in patients at ultra high risk for psychosis.

Maurya PK, Rizzo LB, Xavier G, Tempaku PF, Zeni-Graiff M, Santoro ML, Mazzotti DR, Zugman A, Pan P, Noto C, Maes M, Asevedo E, Mansur RB, Cunha GR, Gadelha A, Bressan RA, Belangero SI, Brietzke E.

Eur Neuropsychopharmacol. 2017 May;27(5):538-542. doi: 10.1016/j.euroneuro.2017.02.008. Epub 2017 Mar 6.

PMID:
28274506
22.

Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.

Matsuzaka CT, Christofolini D, Ota VK, Gadelha A, Berberian AA, Noto C, Mazzotti DR, Spindola LM, Moretti PN, Smith MAC, Melaragno MI, Belangero SI, Bressan RA.

Braz J Psychiatry. 2017 Oct-Dec;39(4):302-308. doi: 10.1590/1516-4446-2016-1987. Epub 2017 Mar 2.

23.

Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M.

Metab Brain Dis. 2017 Aug;32(4):1003-1016. doi: 10.1007/s11011-017-9982-7. Epub 2017 Mar 3.

PMID:
28258445
24.

Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia.

Pinaya WH, Gadelha A, Doyle OM, Noto C, Zugman A, Cordeiro Q, Jackowski AP, Bressan RA, Sato JR.

Sci Rep. 2016 Dec 12;6:38897. doi: 10.1038/srep38897.

25.

New evidence in support of staging approaches in schizophrenia: Differences in clinical profiles between first episode, early stage, and late stage.

Ortiz BB, Eden FD, de Souza AS, Teciano CA, de Lima DM, Noto C, Higuchi CH, Cogo-Moreira H, Bressan RA, Gadelha A.

Compr Psychiatry. 2017 Feb;73:93-96. doi: 10.1016/j.comppsych.2016.11.006. Epub 2016 Nov 18.

PMID:
27923116
26.

Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.

Gouvea ES, Ota VK, Noto C, Santoro ML, Spindola LM, Moretti PN, Carvalho CM, Xavier G, Rios AC, Sato JR, Hayashi MA, Brietzke E, Gadelha A, Bressan RA, Cordeiro Q, Belangero SI.

Transl Psychiatry. 2016 Oct 4;6(10):e908. doi: 10.1038/tp.2016.159.

27.

Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy.

Oprea AD, Noto CJ, Halaszynski TM.

J Clin Anesth. 2016 Nov;34:586-99. doi: 10.1016/j.jclinane.2016.06.016. Epub 2016 Jul 18. Review.

PMID:
27687455
28.

Hair cortisol in drug-naïve first-episode individuals with psychosis.

Andrade EH, Rizzo LB, Noto C, Ota VK, Gadelha A, Daruy-Filho L, Tasso Bde C, Mansur RB, Cordeiro Q, Belangero SI, Bressan RA, Grassi-Oliveira R, Brietzke E.

Braz J Psychiatry. 2016 Mar;38(1):11-6. doi: 10.1590/1516-4446-2014-1634. Epub 2016 Jan 26.

29.

Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder.

Noto MN, Noto C, Caribé AC, Miranda-Scippa Â, Nunes SO, Chaves AC, Amino D, Grassi-Oliveira R, Correll CU, Brietzke E.

Braz J Psychiatry. 2015 Oct-Dec;37(4):280-8. doi: 10.1590/1516-4446-2014-1641.

30.

Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.

Noto C, Ota VK, Santoro ML, Gouvea ES, Silva PN, Spindola LM, Cordeiro Q, Bressan RA, Gadelha A, Brietzke E, Belangero SI, Maes M.

Mol Neurobiol. 2016 Oct;53(8):5701-9. doi: 10.1007/s12035-015-9489-3. Epub 2015 Oct 22.

PMID:
26491028
31.

Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis.

Ota VK, Noto C, Santoro ML, Spindola LM, Gouvea ES, Carvalho CM, Santos CM, Xavier G, Higuchi CH, Yonamine C, Moretti PN, Abílio VC, Hayashi MA, Brietzke E, Gadelha A, Cordeiro Q, Bressan RA, Belangero SI.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2416-25. doi: 10.1016/j.euroneuro.2015.09.013. Epub 2015 Oct 9.

PMID:
26476704
32.

Structural covariance in schizophrenia and first-episode psychosis: An approach based on graph analysis.

Zugman A, Assunção I, Vieira G, Gadelha A, White TP, Oliveira PP, Noto C, Crossley N, Mcguire P, Cordeiro Q, Belangero SI, Bressan RA, Jackowski AP, Sato JR.

J Psychiatr Res. 2015 Dec;71:89-96. doi: 10.1016/j.jpsychires.2015.09.018. Epub 2015 Oct 22.

PMID:
26458012
33.

The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder.

Maurya PK, Noto C, Rizzo LB, Rios AC, Nunes SO, Barbosa DS, Sethi S, Zeni M, Mansur RB, Maes M, Brietzke E.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:134-44. doi: 10.1016/j.pnpbp.2015.08.016. Epub 2015 Sep 6. Review.

PMID:
26348786
34.

Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls.

Zugman A, Pedrini M, Gadelha A, Kempton MJ, Noto CS, Mansur RB, Santoro ML, Gama CS, Bressan RA, McGuire P, Jackowski AP, Brietzke E.

Psychiatry Res. 2015 Oct 30;234(1):84-9. doi: 10.1016/j.pscychresns.2015.08.009. Epub 2015 Aug 28.

PMID:
26341949
35.

Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia.

Gadelha A, Yonamine CM, Nering M, Rizzo LB, Noto C, Cogo-Moreira H, Teixeira AL, Bressan R, Maes M, Brietzke E, Hayashi MA.

Psychiatry Res. 2015 Oct 30;229(3):702-7. doi: 10.1016/j.psychres.2015.08.018. Epub 2015 Aug 12.

PMID:
26296754
36.

Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.

Noto C, Ota VK, Gadelha A, Noto MN, Barbosa DS, Bonifácio KL, Nunes SO, Cordeiro Q, Belangero SI, Bressan RA, Maes M, Brietzke E.

J Psychiatr Res. 2015 Sep;68:210-6. doi: 10.1016/j.jpsychires.2015.07.003. Epub 2015 Jul 3.

PMID:
26228421
37.

High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance.

Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E.

World J Biol Psychiatry. 2015 Sep;16(6):422-429. doi: 10.3109/15622975.2015.1062552. Epub 2015 Jul 27.

PMID:
26212792
38.

Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis.

Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de Farias CC, Moreira EG, Barbosa DS.

Schizophr Res. 2015 Aug;166(1-3):225-30. doi: 10.1016/j.schres.2015.06.009. Epub 2015 Jun 27.

PMID:
26123170
39.

Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.

Santoro ML, Gadelha A, Ota VK, Cunha GR, Asevedo E, Noto CS, Spindola LM, Pan PM, Talarico F, Mansur RB, Silva PN, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI.

World J Biol Psychiatry. 2015 Sep;16(6):441-446. doi: 10.3109/15622975.2015.1048724. Epub 2015 Jun 18.

PMID:
26089098
40.

Determinants of adherence to treatment in first-episode psychosis: a comprehensive review.

Leclerc E, Noto C, Bressan RA, Brietzke E.

Braz J Psychiatry. 2015 Apr-Jun;37(2):168-76. doi: 10.1590/1516-4446-2014-1539. Epub 2015 May 1. Review.

41.

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M.

Mol Neurobiol. 2016 Jul;53(5):2927-2935. doi: 10.1007/s12035-015-9183-5. Epub 2015 May 2. Review.

PMID:
25934103
42.

Omics-based depression and inflammation research.

Maes M, Noto C, Brietzke E.

Braz J Psychiatry. 2015 Jan-Mar;37(1):1-2. doi: 10.1590/1516-4446-2015-3609. No abstract available.

43.

Effects of depression on the cytokine profile in drug naïve first-episode psychosis.

Noto C, Ota VK, Santoro ML, Ortiz BB, Rizzo LB, Higuchi CH, Cordeiro Q, Belangero SI, Bressan RA, Gadelha A, Maes M, Brietzke E.

Schizophr Res. 2015 May;164(1-3):53-8. doi: 10.1016/j.schres.2015.01.026. Epub 2015 Feb 21.

PMID:
25716958
44.

Disorganized Symptoms Predicted Worse Functioning Outcome in Schizophrenia Patients with Established Illness.

Ortiz BB, Gadelha A, Higuchi CH, Noto C, Medeiros D, Pitta JCDN, de Araújo Filho GM, Hallak JEC, Bressan RA.

Clin Schizophr Relat Psychoses. Fall 2017;11(3):151-155. doi: 10.3371/CSRP.ORGA.022015. Epub 2015 Feb 24.

PMID:
25711508
45.

Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.

Noto C, Ota VK, Gouvea ES, Rizzo LB, Spindola LM, Honda PH, Cordeiro Q, Belangero SI, Bressan RA, Gadelha A, Maes M, Brietzke E.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu042. doi: 10.1093/ijnp/pyu042.

46.

Changes in gene expression and methylation in the blood of patients with first-episode psychosis.

Ota VK, Noto C, Gadelha A, Santoro ML, Spindola LM, Gouvea ES, Stilhano RS, Ortiz BB, Silva PN, Sato JR, Han SW, Cordeiro Q, Bressan RA, Belangero SI.

Schizophr Res. 2014 Nov;159(2-3):358-64. doi: 10.1016/j.schres.2014.09.008. Epub 2014 Sep 28.

PMID:
25270546
47.

Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version.

Higuchi CH, Ortiz B, Berberian AA, Noto C, Cordeiro Q, Belangero SI, Pitta JC, Gadelha A, Bressan RA.

Braz J Psychiatry. 2014 Oct-Dec;36(4):336-9. doi: 10.1590/1516-4446-2013-1330. Epub 2014 Jul 16.

48.

What are the PANSS items most related with global improvements in patients with schizophrenia? Toward a reduced version of the PANSS.

Ortiz BB, Gadelha A, Higuchi CH, Pitta JC, Kagan S, Vong MR, Noto C, Hallak JE, Bressan RA.

Schizophr Res. 2014 Sep;158(1-3):277-8. doi: 10.1016/j.schres.2014.06.008. Epub 2014 Jul 5. No abstract available.

PMID:
25008793
49.

Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.

Ota VK, Noto C, Gadelha A, Santoro ML, Ortiz BB, Andrade EH, Tasso BC, Spindola LM, Silva PN, Abílio VC, Smith Mde A, Sato JR, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI.

J Psychiatr Res. 2014 Sep;56:130-6. doi: 10.1016/j.jpsychires.2014.05.012. Epub 2014 Jun 4.

PMID:
24935901
50.

Fluvial transport potential of shed and root-bearing dinosaur teeth from the late Jurassic Morrison Formation.

Peterson JE, Coenen JJ, Noto CR.

PeerJ. 2014 Apr 10;2:e347. doi: 10.7717/peerj.347. eCollection 2014.

Supplemental Content

Support Center